Influence of UCP3 gene polymorphisms on metabolic syndrome and cardiovascular risk in patients with in non-alcoholic fatty liver disease (2017)
- Authors:
- USP affiliated authors: CARRILHO, FLAIR JOSÉ - FM ; CAVALEIRO, ANA MERCEDES DE SOUSA - FM ; GIANNELLA, MARIA LUCIA CARDILLO CORREA - FM
- Unidade: FM
- DOI: 10.1016/S0168-8278(17)30612-8
- Subjects: FÍGADO GORDUROSO; POLIMORFISMO; SÍNDROME X METABÓLICA
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Journal of hepatology
- ISSN: 0168-8278
- Volume/Número/Paginação/Ano: v. 66, supl. 1, p. S167, abstr. THU-381, 2017
- Conference titles: Annual meeting of the European Association for the Study of the Liver
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
TODA, K. S. et al. Influence of UCP3 gene polymorphisms on metabolic syndrome and cardiovascular risk in patients with in non-alcoholic fatty liver disease. Journal of hepatology. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/S0168-8278(17)30612-8. Acesso em: 19 abr. 2024. , 2017 -
APA
Toda, K. S., Stefano, J. T., Costa, F. B., Cavaleiro, A. M., Mazo, D. F., Carrilho, F. J., et al. (2017). Influence of UCP3 gene polymorphisms on metabolic syndrome and cardiovascular risk in patients with in non-alcoholic fatty liver disease. Journal of hepatology. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/S0168-8278(17)30612-8 -
NLM
Toda KS, Stefano JT, Costa FB, Cavaleiro AM, Mazo DF, Carrilho FJ, Correa-Giannella ML, Oliveira CP. Influence of UCP3 gene polymorphisms on metabolic syndrome and cardiovascular risk in patients with in non-alcoholic fatty liver disease [Internet]. Journal of hepatology. 2017 ; 66 S167.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1016/S0168-8278(17)30612-8 -
Vancouver
Toda KS, Stefano JT, Costa FB, Cavaleiro AM, Mazo DF, Carrilho FJ, Correa-Giannella ML, Oliveira CP. Influence of UCP3 gene polymorphisms on metabolic syndrome and cardiovascular risk in patients with in non-alcoholic fatty liver disease [Internet]. Journal of hepatology. 2017 ; 66 S167.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1016/S0168-8278(17)30612-8 - Association of a variant in the regulatory region of NADPH oxidase 4 gene and metabolic syndrome in patients with chronic hepatitis C
- Na DPH oxidase 4 and P22PHOX (CYBA) gene polymorphisms as risk factors dor arterial hypertension and overt nephrolopathy in type 1 diabetes
- Glutathione peroxidase 4 functional variant rs713041 modulates the risk for cardiovascular autonomic neuropathy in individuals with type 1 diabetes [Carta]
- Allelic variations in genes belonging to glutathione system increase proliferative retinopathy risk in type 1 diabetes individuals
- Association between the CYBA and NOX4 genes of NADPH oxidase and its relationship with metabolic syndrome in non-alcoholic fatty liver disease in Brazilian population
- Analysis of insulin-like groth factors and their receptors in HCV-induced cirrhosis and hepatocellular carcinoma
- Protective effect of S-nitroso-N-acetylcysteine (SNAC) in nonalcoholic steatohepatitis (NASH) in ob/ob mice: Downregulation of genes belonging to mitochondrial fatty acids oxidation pathways
- Hyperinsulinism/hyperammonemia (HI/HA) syndrome due to a mutation in the glutamate dehydrogenase gene
- Hepatocyte growth factor-regulated tyrosine kinase substrate (HGS) and guanylate kinase 1 (GUK1) are differentially expressed in GH-secreting adenomas
- Protective effect of Yo Jyo Hen Ko (YHK) in nonalcoholic steatohepatitis atophepatitis (NASH) in OB/OB mice: increased Ppar-alfa gene expression
Informações sobre o DOI: 10.1016/S0168-8278(17)30612-8 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
